Art Technology Acquisition Corp. (NASDAQ:ARTC)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
ARTC Weekly Chart

Old Forum Content for ARTC

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • southern: $ARTC ArthroCare disclosed it received a Civil Investigative Demand from the DOJ, requesting information related to its marketing of its radio-frequency ablation devices; Co cannot predict the ultimate outcome ....Co disclosed that on February 8, 2012, it received a Civil Investigative Demand from the DOJ, requesting information related to its marketing of its radio-frequency ablation devices, which could implicate the False Claims Act, 31 U.S.C. 3729. Co is cooperating fully with the investigation, although it can give no assurances regarding the duration of the investigation or whether proceedings will be instituted against it. Co intends to represent the Company's interests vigorously in this matter. At this stage of the investigation, however, the co cannot predict the ultimate outcome of the investigation or any potential liability we may incur. @Tricia are you the @Tricia from the Rev's blog..Do remember when we bought ATRC? That is still doing so well!
  • evanesce: Hi @Craigy, This was a simple credit spread - just like the ones I described Friday in the new tutorial. I wasn't so much expecting $ARTC to plummet, I was expecting its one-week price action to be contained below $50. One related strategy I often use is not discussed in any of the "standards". If I was pretty sure that $ARTC was going to drop, I might have bought puts equal in value to what I received from selling the credit spread. In this case I got $0.60 per "share" from the spread, so I might have looked through the FEB chains and picked up half as many puts costing $1.20 per "share". That would have given me a zero-outlay bearish position with a pre-defined risk. (I'll describe variants of this strategy as I get some quality writing time.) Does this come close to answering your question? Hope so....
  • evanesce: ARTC: @HorseTrader brought this to our attention a little while ago. For those inclined to the short side, this could be a good opportunity. ArthoCare has been in a downtrending channel since early November. Regarding sentiment, the bullies at StockLemon have been pressing hard, creating negative press. The stock was rising into Needham's Growth Stock conference, but the $ARTC presentation yesterday left much to be desired and it is again falling. Technically, this is a great entry because yesterday it managed to tag the upper Bollinger band (intra-day, it closed lower). I'm torn between selling calls and buying puts, perhaps I'll do both.
  • HorseTrader: @qureshir: @Andrew Left just attacked $ARTC a couple weeks ago, so you'll be joining a bandwagon. If you want to read his typical false truths, check out citronresearch.com. Good luck!
  • qureshir: Hi, What does everyone think of $ARTC as a short? Its below both its 50dma and 200dma and has been rising on moderate to low volume. Riz
  • unice: Let's just @chill out here. Damn you Citigroup... Look at this $ARTC holders holding tight. Buyers showing up too.
  • nivekelly: Hey everyone...new member. I've been watching $ARTC since it broke out the other day and it looks like it's legging up again today -- thoughts? Watching $CNET closely for a completed breakdown, I'd love to short this thing.
Visit the Trading Forum to join in the discussion.
Stock Price $9.81
Change 0.10%
Volume 134

ArthroCare Corporation a multi-business medical device company that develops, manufactures and markets invasive surgical products.

Request Video of ARTC
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!